Bennebroe, Netherlands
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Phase
2Span
95 weeksSponsor
Eli Lilly and CompanySoka, Saitama
Recruiting
Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
Phase
3Span
277 weeksSponsor
Juntendo UniversitySoka, Saitama
Recruiting
1-2 of 2